Multimodal risk reduction
1 paper
- Humans1
Related
- Alzheimer's disease1
- Aβ42/Aβ40 ratio1
- Lipid and ceramide metabolism1
- Proteostasis1
- SNCA1
- Alpha-synuclein markers1
- Amyloid-beta 401
- Amyloid-beta 421
- Ezetimibe1
- GLP-1 receptor agonists1
- Hormone replacement therapy1
- Lifestyle changes1
- Lipid-lowering agents1
- Neurodegenerative disease1
- Oligomeric alpha-synuclein/total alpha-synuclein ratio1
- pTau181/Aβ42 ratio1